| 000 | 01912 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516061126.0 | ||
| 264 | 0 | _c20130117 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2011.04.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhuang, Weiliang | |
| 245 | 0 | 0 |
_aThe mechanism of the G0/G1 cell cycle phase arrest induced by activation of PXR in human cells. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cOct 2011 |
||
| 300 |
_a467-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aG1 Phase _xdrug effects |
| 650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 |
_aHep G2 Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuroblastoma _xpathology |
| 650 | 0 | 4 | _aPregnane X Receptor |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aReceptors, Steroid _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xphysiology |
| 650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aRetinoid X Receptor alpha _xgenetics |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 |
_aUltraviolet Rays _xadverse effects |
| 700 | 1 | _aJia, Zhenhua | |
| 700 | 1 | _aFeng, Huahua | |
| 700 | 1 | _aChen, Jun | |
| 700 | 1 | _aWang, Hang | |
| 700 | 1 | _aGuo, Yanghao | |
| 700 | 1 | _aMeng, Chun | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 65 _gno. 7 _gp. 467-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2011.04.014 _zAvailable from publisher's website |
| 999 |
_c21233012 _d21233012 |
||